Rockefeller Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Rockefeller Capital Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-288	Closed	-$2K	–	4575
2022 Q2	$2K	Buy	+288	New	+$2.03K	﹤0.01%	3882
2021 Q4	–	Sell	-655	Closed	-$7K	–	4082
2021 Q3	$7K	Hold	655	–	–	﹤0.01%	3072
2021 Q2	$10K	Buy	+655	New	+$11.2K	﹤0.01%	2797
2020 Q4	–	Sell	-457	Closed	-$5K	–	3062
2020 Q3	$5K	Buy	457 +167	+58%	+$2.03K	﹤0.01%	2251
2020 Q2	$4K	Sell	290 -138	-32%	-$2.04K	﹤0.01%	2189
2020 Q1	$6K	Buy	+428	New	+$8.12K	﹤0.01%	1923
2019 Q2	–	Sell	-20	Closed	-$1K	–	2060
2019 Q1	$1K	Buy	+20	New	+$880	﹤0.01%	1895

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rockefeller Capital Management's AERI Position: Q3 2022 in Review

Rockefeller Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 288 shares — an estimated $2K sold.

Rockefeller Capital Management first reported a position in AERI in Q1 2019 and held it in 7 quarters. The position peaked at $10K in Q2 2021. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

Rockefeller Capital Management reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Rockefeller Capital Management sold 288 Aerie Pharmaceuticals shares in Q3 2022, an estimated $2K.
Rockefeller Capital Management first reported a position in Aerie Pharmaceuticals in Q1 2019 and held it in 7 quarters.
Rockefeller Capital Management's Aerie Pharmaceuticals position peaked at $10K in Q2 2021.
156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Rockefeller Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.